BNTX

BioNTech SE

Price

$90.26

return (12m)

-11.56%

p/e

-17.13

p/bv

1.15

DIVIDEND YIELD

0.00%

BNTX price

BioNTech

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment BNTX

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-9.54%

3 months

-0.15%

1 year

-11.56%

2 years

-25.11%

5 years

-63.94%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals BNTX

Valuation

P/E

-17.13

Sector -3.34

Industry -3.34

P/BV

1.15

Sector 1.89

Industry 1.89

P/Revenue (PSR)

7.58

Sector 2.04

Industry 2.04

EV/EBITDA

-15.67

Sector -219.22

Industry -219.22

EV/EBIT

-12.30

Sector -47.87

Industry -47.87

P/EBITDA

-41.49

Sector -22.33

Industry -22.33

P/EBIT

-21.87

Sector -28.88

Industry -28.88

P/Total Assets

1.02

Sector 1.11

Industry 1.11

P/Net Current Assets

1.64

Sector -9.46

Industry -9.46

P/Working Capital

1.56

Sector -148.60

Industry -148.60

EPS

-5.74

Sector -1.78

Industry -1.78

BVPS

85.44

Sector 1.98

Industry 1.98

Efficiency

Gross Margin

77.61%

Sector 41.35%

Industry 41.35%

EBITDA Margin

-374.94%

Sector -17,192.92%

Industry -17,192.92%

EBIT Margin

-27.08%

Sector -35.47%

Industry -35.47%

Net Profit Margins

-44.22%

Sector -35.90%

Industry -35.90%

Asset Turnover

0.01

Sector 0.03

Industry 0.03

Profitability

ROE

-6.72%

Sector -57.36%

Industry -57.36%

ROA

-5.96%

Sector -59.44%

Industry -59.44%

ROIC

-35.21%

Sector -2,371.18%

Industry -2,371.18%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

8.80

Sector 2.91

Industry 2.91

Net Debt / EBITDA

32.91

Sector -21.45

Industry -21.45

Net Debt / EBIT

25.83

Sector -8.32

Industry -8.32

Net Debt / Equity

-0.78

Sector -33,201.77

Industry -33,201.77

Gross Debt / Equity

0.00

Sector -0.85

Industry -0.85

Equity/Assets

0.89

Sector 0.46

Industry 0.46

Liabilities/Assets

0.11

Sector 0.41

Industry 0.41

Growth

5Y Revenue CAGR

-31.80%

Sector -

Industry -

5Y Earnings CAGR

0.00%

Sector -

Industry -

Fundamentals BNTX

DRAG THE FRAME TO SEE MORE DATA

Assets	Price ($)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
BNTX BioNTech SE	$90.26	-11.56%	0.00%	-17.13	1.15	-6.72%	-44.22%
PFE Pfizer Inc.	$28.25	23.91%	6.23%	36.34	1.84	5.07%	6.80%
ABBV AbbVie Inc.	$276.61	23.83%	2.47%	77.50	-82.49	-106.44%	9.81%
NVO Novo Nordisk A/S	$38.20	-30.25%	4.83%	9.39	4.99	53.11%	35.32%
MRK Merck & Co. Inc.	$142.71	70.83%	2.34%	113.15	8.55	7.56%	4.77%
AZN AstraZeneca PLC	$157.00	-5.51%	2.03%	19.02	4.90	25.77%	16.95%
BMY Bristol-Myers Squibb Company	$56.36	35.67%	4.26%	12.97	5.39	41.59%	18.87%
ZTS Zoetis Inc.	$75.14	-45.73%	2.81%	11.76	9.85	83.77%	27.69%
AMGN Amgen Inc.	$414.70	46.88%	2.41%	25.51	19.08	74.80%	22.95%
REGN Regeneron Pharmaceuticals Inc.	$750.47	35.09%	0.49%	17.80	2.43	13.65%	27.86%
HALO Halozyme Therapeutics Inc.	$109.37	70.62%	0.00%	31.72	91.40	288.13%	24.86%
MCK McKesson Corporation	$962.85	26.60%	0.36%	24.20	-28.76	-118.84%	1.12%
VRTX Vertex Pharmaceuticals Incorporated	$489.96	20.15%	0.00%	29.37	6.39	21.76%	35.00%
CAH Cardinal Health Inc.	$237.45	53.30%	0.86%	32.46	-20.43	-62.92%	0.67%
ARGX argenx SE	$803.12	0.78%	0.00%	15.66	4.13	26.35%	25.62%
HRMY Harmony Biosciences Holdings Inc.	$36.74	38.43%	0.00%	12.88	2.34	18.14%	18.88%
BIIB Biogen Inc.	$228.84	56.13%	0.00%	40.08	1.77	4.43%	8.32%
MEDP Medpace Holdings Inc.	$613.71	22.44%	0.00%	35.35	40.05	113.29%	17.67%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

BNTX - Historical Dividends

Current Dividend Yield

0.00%

5-year average Dividend Yield

0.35%

Current Payout

—

5-year average Payout

1.72%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	06/01/2022	06/17/2022	2.11100000

ABOUT BioNTech

BioNTech SE

Average Investor10 user rating

4.0 (25 people)

United States

18 years

Founded: 2008

2019

Time since IPO - 7 years

1.300

Employees

BioNTech SE (United States) is listed on the Nasdaq and has a market capitalization of $24.87 billion, with shareholders equity totaling $21.62 billion.

The company employs approximately 1.300 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, BioNTech SE reported $3.28 billion in revenue, generating net income of $-1.45 billion.

Key financial metrics include a P/E ratio of -17.13, a price-to-book (P/B) ratio of 1.15, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker BNTX.

Market cap

$24.87 billion

Net worth

$21.62 billion

$21,615,950,000.00

Assets

$24.36 billion

$24,363,120,000.00

Total Shares Outstanding

253.00 million

253,000,000

Average Daily Trading Volume

$1.24 million

$1,244,999.24

Sector

Health Care

Industry

Biotechnology

BNTX

revenue by Business Segment BioNTech

Revenue by Region BioNTech

BNTX revenue and profits

Financial Results BNTX

DRAG THE FRAME TO SEE MORE DATA

BNTX cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$962.85 25,62% (12M)

P/E

24.20

0.36%

ROE

-118.84%

P/BV

-28.76

CAH - Cardinal Health

$237.45 55,85% (12M)

P/E

32.46

0.86%

ROE

-62.92%

P/BV

-20.43

ABBV - AbbVie

$276.61 23,94% (12M)

P/E

77.50

2.47%

ROE

-106.44%

P/BV

-82.49

MRK - Merck & Co.

$142.71 71,41% (12M)

P/E

113.15

2.34%

ROE

7.56%

P/BV

8.55

AZN - AstraZeneca

$157.00 --6,19% (12M)

P/E

19.02

2.03%

ROE

25.77%

P/BV

4.90

PFE - Pfizer

$28.25 24,16% (12M)

P/E

36.34

6.23%

ROE

5.07%

P/BV

1.84

BMY - Bristol-Myers Squibb

$56.36 36,98% (12M)

P/E

12.97

4.26%

ROE

41.59%

P/BV

5.39

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$962.85 25,62% (12 M)

P/L

24.20

0.36%

ROE

-118.84%

P/VP

-28.76

CAH - Cardinal Health

$237.45 55,85% (12 M)

P/L

32.46

0.86%

ROE

-62.92%

P/VP

-20.43

ABBV - AbbVie

$276.61 23,94% (12 M)

P/L

77.50

2.47%

ROE

-106.44%

P/VP

-82.49

MRK - Merck & Co.

$142.71 71,41% (12 M)

P/L

113.15

2.34%

ROE

7.56%

P/VP

8.55

AZN - AstraZeneca

$157.00 --6,19% (12 M)

P/L

19.02

2.03%

ROE

25.77%

P/VP

4.90

PFE - Pfizer

$28.25 24,16% (12 M)

P/L

36.34

6.23%

ROE

5.07%

P/VP

1.84

BMY - Bristol-Myers Squibb

$56.36 36,98% (12 M)

P/L

12.97

4.26%

ROE

41.59%

P/VP

5.39

Frequently Asked Questions

What is the price of BioNTech (BNTX) today?

The current price of BioNTech (BNTX) is $90.26. The stock began the year trading around $95.20 and is currently priced at $90.26. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does BioNTech (BNTX) pay dividends?

BioNTech (BNTX) did not pay dividends over the past year.

Is BioNTech (BNTX) a good investment?

BioNTech (BNTX) is currently trading at $90.26 with a P/E ratio of -17.13. This represents a -868% premium compared to its historical average P/E. Over the past year, the stock paid $0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was -11.56%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy BioNTech (BNTX) stock?

You can buy BioNTech (BNTX) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol BNTX and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of BioNTech (BNTX) yield today?

Over the past month, BioNTech (BNTX) has returned -9.54% — -11.56% over the past year, and -63.94% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 0.00 per share in dividends, resulting in a dividend yield of 0.00%.

If you were to purchase 100 shares of BioNTech (BNTX) today at the current price of $90.26 your total investment would be $9,026.00.

Based on historical performance, the investment would have grown to approximately:

$7,982.59 after 1 year
$3,254.78 after 5 years
$9,026.00 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

BNTX

BioNTech SE

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment BNTX

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING BNTX WITH OTHER STOCK

type

Ex - Dividend Date

payment date

value

ABOUT BioNTech

BioNTech SE

United States

18 years

2019

1.300

PROFIT X PRICE BNTX

Financial Results BNTX

BNTX cash flow

Asset, Revenue and Profit Growth - BNTX

BNTX balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BMY - Bristol-Myers Squibb

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BMY - Bristol-Myers Squibb

Frequently Asked Questions